Manufacturer financial conflicts of interest are associated with favourable outcomes in randomised controlled trials of liposomal bupivacaine

Authors

Kevin J. Finkel, Integrated Anesthesia Associates, LLC, Hartford Hospital, Hartford, CT, USA. Electronic address: kevin.finkel@hhchealth.org.
Edmund T. Takata, Integrated Anesthesia Associates, LLC, Hartford Hospital, Hartford, CT, USA.
Carla L. Maffeo-Mitchell, Integrated Anesthesia Associates, LLC, Hartford Hospital, Hartford, CT, USA.
Jonathan B. Neal, University of Connecticut School of Medicine, Farmington, CT, USA.
Matthew D. Nankin, Frank H. Netter School of Medicine, Quinnipiac University, North Haven, CT, USA.
Barbara H. Braffett, George Washington University, Washington, DC, USA.
Lauren M. Perillo, Integrated Anesthesia Associates, LLC, Hartford Hospital, Hartford, CT, USA.
Samuel Gammerman, Integrated Anesthesia Associates, LLC, Hartford Hospital, Hartford, CT, USA.
William T. Stuart, Integrated Anesthesia Associates, LLC, Hartford Hospital, Hartford, CT, USA.
Aseel Walker, Integrated Anesthesia Associates, LLC, Hartford Hospital, Hartford, CT, USA.

Document Type

Letter to the Editor

Publication Date

8-15-2022

Journal

British journal of anaesthesia

DOI

10.1016/j.bja.2022.06.032

Keywords

EXPAREL; analgesia; bupivacaine; conflict of interest; financial disclosure; liposomal bupivacaine; regional anaesthesia

APA Citation

Finkel, Kevin J.; Takata, Edmund T.; Maffeo-Mitchell, Carla L.; Neal, Jonathan B.; Nankin, Matthew D.; Braffett, Barbara H.; Perillo, Lauren M.; Gammerman, Samuel; Stuart, William T.; and Walker, Aseel, "Manufacturer financial conflicts of interest are associated with favourable outcomes in randomised controlled trials of liposomal bupivacaine" (2022). GW Authored Works. Paper 1476.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/1476

Department

Epidemiology